Lifevantage (NASDAQ:LFVN) Director Judd Dayton Acquires 18,097 Shares of Stock

Lifevantage Corporation (NASDAQ:LFVN) Director Judd Dayton bought 18,097 shares of the firm’s stock in a transaction on Friday, February 27th. The shares were purchased at an average price of $4.63 per share, for a total transaction of $83,789.11. Following the purchase, the director owned 69,859 shares in the company, valued at $323,447.17. This trade represents a 34.96% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website.

Judd Dayton also recently made the following trade(s):

• On Monday, March 2nd, Judd Dayton bought 10,500 shares of Lifevantage stock. The shares were purchased at an average price of $4.53 per share, for a total transaction of $47,565.00.
• On Thursday, February 26th, Judd Dayton bought 4,600 shares of Lifevantage stock. The stock was purchased at an average cost of $4.58 per share, with a total value of $21,068.00.

Lifevantage Stock Down 2.8%

LFVN stock traded down $0.13 during trading on Monday, reaching $4.52. The company’s stock had a trading volume of 155,943 shares, compared to its average volume of 238,601. The company’s fifty day moving average is $5.64 and its 200-day moving average is $7.92. The company has a market capitalization of $57.82 million, a P/E ratio of 7.53 and a beta of 0.33. Lifevantage Corporation has a 1 year low of $3.90 and a 1 year high of $17.64.

Lifevantage (NASDAQ:LFVN) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.07). Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. The business had revenue of $48.93 million during the quarter, compared to analysts’ expectations of $54.40 million. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 4.0%. The ex-dividend date is Monday, March 2nd. Lifevantage’s dividend payout ratio is presently 30.00%.

Institutional Investors Weigh In On Lifevantage

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Capital Management Corp VA increased its position in shares of Lifevantage by 63.0% during the 3rd quarter. Capital Management Corp VA now owns 2,064,176 shares of the company’s stock valued at $20,084,000 after purchasing an additional 798,066 shares during the last quarter. Los Angeles Capital Management LLC bought a new stake in Lifevantage in the second quarter worth $288,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Lifevantage during the second quarter worth $784,000. AlphaQuest LLC boosted its stake in Lifevantage by 12,659.7% during the second quarter. AlphaQuest LLC now owns 7,911 shares of the company’s stock worth $103,000 after buying an additional 7,849 shares during the period. Finally, Renaissance Technologies LLC increased its position in Lifevantage by 8.3% during the fourth quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock valued at $5,685,000 after acquiring an additional 70,900 shares during the last quarter. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on LFVN shares. Loop Capital set a $5.00 target price on shares of Lifevantage in a report on Thursday, February 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a report on Monday, December 29th. Wall Street Zen cut shares of Lifevantage from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Lake Street Capital reissued a “buy” rating on shares of Lifevantage in a report on Thursday, February 5th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $5.00.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.